Nothing Special   »   [go: up one dir, main page]

DE60120139D1 - Verfahren zur herstellung von camptothectin - Google Patents

Verfahren zur herstellung von camptothectin

Info

Publication number
DE60120139D1
DE60120139D1 DE60120139T DE60120139T DE60120139D1 DE 60120139 D1 DE60120139 D1 DE 60120139D1 DE 60120139 T DE60120139 T DE 60120139T DE 60120139 T DE60120139 T DE 60120139T DE 60120139 D1 DE60120139 D1 DE 60120139D1
Authority
DE
Germany
Prior art keywords
camptothectin
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60120139T
Other languages
English (en)
Other versions
DE60120139T2 (de
Inventor
Takashi Yaegashi
Takanori Ogawa
Seigo Sawada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yakult Honsha Co Ltd
Original Assignee
Yakult Honsha Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yakult Honsha Co Ltd filed Critical Yakult Honsha Co Ltd
Application granted granted Critical
Publication of DE60120139D1 publication Critical patent/DE60120139D1/de
Publication of DE60120139T2 publication Critical patent/DE60120139T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60120139T 2000-03-22 2001-03-21 Verfahren zur herstellung von camptothecin Expired - Lifetime DE60120139T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000079385 2000-03-22
JP2000079385 2000-03-22
PCT/JP2001/002216 WO2001070747A1 (fr) 2000-03-22 2001-03-21 Procede de production de camptothecine

Publications (2)

Publication Number Publication Date
DE60120139D1 true DE60120139D1 (de) 2006-07-06
DE60120139T2 DE60120139T2 (de) 2007-04-12

Family

ID=18596639

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60120139T Expired - Lifetime DE60120139T2 (de) 2000-03-22 2001-03-21 Verfahren zur herstellung von camptothecin

Country Status (14)

Country Link
US (1) US6743918B2 (de)
EP (1) EP1270579B1 (de)
JP (1) JP4624633B2 (de)
KR (1) KR100757463B1 (de)
CN (1) CN1228341C (de)
AR (1) AR027687A1 (de)
AT (1) ATE327995T1 (de)
AU (2) AU4273501A (de)
BR (1) BR0109343A (de)
CA (1) CA2402364C (de)
DE (1) DE60120139T2 (de)
MX (1) MXPA02009203A (de)
TW (1) TWI287016B (de)
WO (1) WO2001070747A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ299329B6 (cs) * 2003-08-26 2008-06-18 Pliva-Lachema A.S. Zpusob výroby 7-ethyl-10-[ 4-(1-piperidino)-1-piperidino]karbonyloxykamptothecinu
CZ299593B6 (cs) * 2003-12-16 2008-09-10 Pliva-Lachema A. S. Zpusob výroby 7-ethyl-10-hydroxykamptothecinu
TWI396690B (zh) 2006-04-27 2013-05-21 Yakult Honsha Kk 喜樹鹼衍生物的製造方法
CN108570057A (zh) * 2017-03-13 2018-09-25 烟台药物研究所 一种合成7-乙基-10-羟基喜树碱的方法
CN113880855A (zh) * 2021-09-02 2022-01-04 兰州大学 一种9-氟喜树碱衍生物的制备及其在抗肿瘤方面的用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6019790A (ja) * 1983-07-14 1985-01-31 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体
US4496555A (en) * 1983-07-19 1985-01-29 Wayne State University Compounds and compositions for inhibiting estrogen sulfotransferase transferase activity, process and novel intermediates therein
US4568673A (en) * 1984-03-20 1986-02-04 Wayne State University Compositions inhibiting murine MXT ductal carcinoma
JPS6185319A (ja) * 1984-10-03 1986-04-30 Yakult Honsha Co Ltd 抗腫瘍剤
EP0254737B1 (de) * 1986-01-16 1990-07-25 Schering Corporation Kondensierte benzazepine
US4981968A (en) * 1987-03-31 1991-01-01 Research Triangle Institute Synthesis of camptothecin and analogs thereof
JP2538792B2 (ja) 1987-06-25 1996-10-02 株式会社ヤクルト本社 新規なカンプトテシン誘導体
US4868291A (en) * 1987-08-20 1989-09-19 Bristol-Myers Company 4'-deshydroxyepipodophyllotoxin glucosides: synthesis and use
US5004758A (en) * 1987-12-01 1991-04-02 Smithkline Beecham Corporation Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells
JPH0615547B2 (ja) * 1988-01-20 1994-03-02 株式会社ヤクルト本社 新規なカンプトテシン誘導体
JPH0873461A (ja) 1994-09-06 1996-03-19 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体、その製造法および抗腫瘍剤
JP4094710B2 (ja) 1997-11-06 2008-06-04 株式会社ヤクルト本社 新規なカンプトテシン誘導体

Also Published As

Publication number Publication date
CA2402364A1 (en) 2001-09-27
EP1270579B1 (de) 2006-05-31
AR027687A1 (es) 2003-04-09
KR100757463B1 (ko) 2007-09-11
JP4624633B2 (ja) 2011-02-02
AU2001242735B2 (en) 2005-05-26
US6743918B2 (en) 2004-06-01
ATE327995T1 (de) 2006-06-15
CA2402364C (en) 2008-07-08
KR20020087071A (ko) 2002-11-21
DE60120139T2 (de) 2007-04-12
MXPA02009203A (es) 2004-04-02
EP1270579A4 (de) 2004-07-07
EP1270579A1 (de) 2003-01-02
AU4273501A (en) 2001-10-03
WO2001070747A1 (fr) 2001-09-27
BR0109343A (pt) 2002-12-17
CN1419558A (zh) 2003-05-21
TWI287016B (en) 2007-09-21
CN1228341C (zh) 2005-11-23
US20040087609A1 (en) 2004-05-06

Similar Documents

Publication Publication Date Title
DE122007000077I1 (de) Verfahren zur Herstellung von substituierten Octanoyl-Amiden
DE60142487D1 (de) Verfahren zur herstellung von liposomen
DE60125747D1 (de) Verfahren zur herstellung von 2-halobenzoesäuren
DE60111747D1 (de) Verfahren zur herstellung von infektiösen reoviren
DE50112916D1 (de) Verfahren zur herstellung von alkylarylsulfonaten
DE60106933D1 (de) Verfahren zur herstellung von citalopram
DE50201891D1 (de) Verfahren zur herstellung von 1-octen
DE60223070D1 (de) Verfahren zur herstellung von dihalogenadamantanen
DE60117106D1 (de) Verfahren zur Herstellung von Halopropyldimethylchlorosilanen
DE60019747D1 (de) Verfahren zur herstellung von fluorolefinen
DE60219193D1 (de) Verfahren zur herstellung von silylorganomercaptanen
DE60208738D1 (de) Verfahren zur Herstellung von Chlorfluorpolyoxyalkylenolen
DE60026607T8 (de) Verfahren zur Herstellung von Perfluoralkadienen
DE60104244D1 (de) Verfahren zur Herstellung von Amiden
DE50103049D1 (de) Verfahren zur Herstellung von Aminodiphenylaminen
DE60110898D1 (de) Verfahren zur herstellung von xylol
DE60127538D1 (de) Verfahren zur herstellung von methionin
DE60116874D1 (de) Verfahren zur herstellung von (r)-2-alkyl-3-phenyl-1-propanolen
DE60131954D1 (de) Verfahren zur herstellung von 2-hydroxy-4-methylthiobutansäure
DE50210487D1 (de) Verfahren zur Herstellung von 1-Amino-4-hydroxyanthrachinonen
DE60133280D1 (de) Verfahren zur herstellung von citalopram
DE60024372D1 (de) Verfahren zur Herstellung von Tetraorganooxysilanen
DE60101124D1 (de) Verfahren zur Herstellung von Sulfinaten
DE60102763D1 (de) Verfahren zur Herstellung von Dihydroperimidin-Squarainverbindungen
DE60209171D1 (de) Verfahren zur Herstellung von Bromfluorenen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition